0 Yorumlar
0 hisse senetleri
230 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Endovenous Ablation Devices Market Trends, Insights and Future OutlookExecutive Summary Endovenous Ablation Devices Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyses that the endovenous ablation devices market which is expected to reach a CAGR of 6% during the forecast period 2022 to 2029 This global Endovenous Ablation Devices Market research report is organized by collecting market research data from different...0 Yorumlar 0 hisse senetleri 157 Views 0 önizleme
-
Electrophysiology Devices Market Insights 2025–2034 | Growth from US$ 11.09B to US$ 26.61BThe Electrophysiology industry centers on technologies that analyze and correct abnormal heart rhythms. From diagnostic mapping tools to ablation devices, it plays a vital role in managing arrhythmias and enhancing cardiovascular care. Electrophysiology Market Growth Analysis The Electrophysiology Market is projected to grow significantly from US$ 11.09 billion in 2025 to US$ 26.61...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme1
-
Global Tissue Ablation Market Size, Share & Growth Forecast 2025–2031 | CAGR 7.2%According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031. Glycated hemoglobin (HbA1c) testing serves as the gold standard for diabetes management...0 Yorumlar 0 hisse senetleri 563 Views 0 önizleme
-
Global Tissue Ablation Market Size, Share & Growth Forecast 2025–2031 | CAGR 7.2%According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031. Glycated hemoglobin (HbA1c) testing serves as the gold standard for diabetes management...0 Yorumlar 0 hisse senetleri 593 Views 0 önizleme